Watkins Glen, NY, United States of America

Chris Pelletier

This inventor holds 2 USPTO granted patents. Top assignee: Tdbt IP Inc.. Active years: 2022-2025.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Chris Pelletier: Innovator in 3D Printing Bio Gel Technology

Introduction

Chris Pelletier is an accomplished inventor based in Watkins Glen, NY (US). He has made significant contributions to the field of 3D printing, particularly in the development of bio gel technologies. With a total of 2 patents, Pelletier is recognized for his innovative approaches to collagen compositions and their applications.

Latest Patents

Pelletier's latest patents include groundbreaking work on 3D printing bio gel and methods of use. His first patent focuses on collagen compositions, methods for preparing those collagen compositions, and 3D constructs formed from those collagen compositions. This patent emphasizes methods of isolating collagen that exhibits an enhanced rate of gelling. The second patent also revolves around 3D printable bio gel, detailing similar collagen compositions and methods for their preparation, further advancing the field of bioengineering.

Career Highlights

Chris Pelletier is currently associated with Tdbt IP Inc., where he continues to push the boundaries of innovation in his field. His work has garnered attention for its potential applications in various industries, including medical and biotechnological fields.

Collaborations

Pelletier collaborates with Daniel L Cohen, leveraging their combined expertise to enhance their research and development efforts.

Conclusion

Chris Pelletier stands out as a key figure in the realm of 3D printing bio gel technology. His innovative patents and ongoing work at Tdbt IP Inc. highlight his commitment to advancing the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…